Article
Second-generation compound for the modulation of utrophin in the therapy of DMD
1 May 2015
Abstract excerpt
Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of the cytoskeletal protein dystrophin. There is currently no cure for DMD although various promising approaches are progressing through human clinical trials. By pharmacologically modulating the expression of the dystrophin-related protein utrophin, we have previously demonstrated in dystrophin-deficient mdx studies,...
Topics
Join the communities discussing this publication.